0001209191-16-152916.txt : 20161202
0001209191-16-152916.hdr.sgml : 20161202
20161202142237
ACCESSION NUMBER: 0001209191-16-152916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161130
FILED AS OF DATE: 20161202
DATE AS OF CHANGE: 20161202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 162030732
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-30
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2016-11-30
4
M
0
6500
36.30
A
274725
D
Common Stock
2016-11-30
4
S
0
2200
82.20
D
272525
D
Common Stock
2016-11-30
4
S
0
2100
83.48
D
270425
D
Common Stock
2016-11-30
4
S
0
1700
84.53
D
268725
D
Common Stock
2016-11-30
4
S
0
500
85.53
D
268225
D
Common Stock
13286
I
401k
Common Stock
78200
I
Common Stock Held In Trust
Stock Option (Right to Buy)
36.30
2016-11-30
4
M
0
6500
0.00
D
2017-01-23
Common Stock
6500
40500
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $82.20 (range $81.90 to $82.74).
Open market sales reported on this line occurred at a weighted average price of $83.48 (range $82.97 to $83.80).
Open market sales reported on this line occurred at a weighted average price of $84.53 (range $84.14 to $85.00).
Open market sales reported on this line occurred at a weighted average price of $85.53 (range $85.35 to $85.85).
Fully vested.
Omar White, Attorney-In-Fact
2016-12-02